American National Bank Raises Stock Position in UnitedHealth Group Inc (NYSE:UNH)

American National Bank increased its holdings in shares of UnitedHealth Group Inc (NYSE:UNH) by 2.4% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 31,911 shares of the healthcare conglomerate’s stock after purchasing an additional 738 shares during the period. UnitedHealth Group makes up 2.1% of American National Bank’s holdings, making the stock its 12th biggest position. American National Bank’s holdings in UnitedHealth Group were worth $6,935,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. Eastern Bank boosted its position in UnitedHealth Group by 2.0% during the second quarter. Eastern Bank now owns 69,088 shares of the healthcare conglomerate’s stock worth $16,858,000 after acquiring an additional 1,375 shares during the last quarter. Private Advisors LLC grew its holdings in UnitedHealth Group by 57.9% during the 1st quarter. Private Advisors LLC now owns 6,501 shares of the healthcare conglomerate’s stock worth $1,607,000 after acquiring an additional 2,385 shares in the last quarter. Capital Investment Advisors LLC boosted its holdings in shares of UnitedHealth Group by 26.2% in the 2nd quarter. Capital Investment Advisors LLC now owns 6,379 shares of the healthcare conglomerate’s stock valued at $1,556,000 after buying an additional 1,323 shares in the last quarter. Berkeley Capital Partners LLC boosted its holdings in shares of UnitedHealth Group by 7.4% in the 2nd quarter. Berkeley Capital Partners LLC now owns 2,220 shares of the healthcare conglomerate’s stock valued at $542,000 after buying an additional 153 shares in the last quarter. Finally, Calton & Associates Inc. boosted its holdings in shares of UnitedHealth Group by 22.7% in the 2nd quarter. Calton & Associates Inc. now owns 2,074 shares of the healthcare conglomerate’s stock valued at $506,000 after buying an additional 384 shares in the last quarter. 85.66% of the stock is owned by hedge funds and other institutional investors.

In other UnitedHealth Group news, Director Richard T. Burke sold 2,000 shares of the firm’s stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $231.50, for a total transaction of $463,000.00. Following the sale, the director now directly owns 187,979 shares of the company’s stock, valued at approximately $43,517,138.50. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director William C. Ballard, Jr. sold 12,000 shares of the firm’s stock in a transaction dated Tuesday, July 23rd. The stock was sold at an average price of $255.31, for a total transaction of $3,063,720.00. Following the sale, the director now directly owns 61,309 shares in the company, valued at $15,652,800.79. The disclosure for this sale can be found here. Insiders have sold a total of 24,000 shares of company stock worth $5,924,120 over the last ninety days. 0.87% of the stock is owned by corporate insiders.



A number of analysts recently weighed in on UNH shares. Raymond James increased their price target on shares of UnitedHealth Group from $265.00 to $300.00 and gave the stock a “buy” rating in a research note on Friday, July 19th. Deutsche Bank initiated coverage on shares of UnitedHealth Group in a research report on Thursday, September 12th. They set a “hold” rating and a $263.00 price objective for the company. Jefferies Financial Group downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating and cut their price objective for the stock from $300.00 to $235.00 in a research report on Thursday. Morgan Stanley cut their price objective on shares of UnitedHealth Group from $298.00 to $294.00 and set an “overweight” rating for the company in a research report on Thursday, September 26th. Finally, Oppenheimer set a $312.00 price objective on shares of UnitedHealth Group and gave the stock a “buy” rating in a research report on Friday, July 19th. Five investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. UnitedHealth Group has a consensus rating of “Buy” and a consensus price target of $283.78.

NYSE:UNH traded up $1.42 during mid-day trading on Thursday, hitting $223.50. 2,698,390 shares of the company’s stock traded hands, compared to its average volume of 4,488,347. The company has a debt-to-equity ratio of 0.62, a quick ratio of 0.67 and a current ratio of 0.67. The firm’s 50 day simple moving average is $227.85 and its 200 day simple moving average is $240.32. UnitedHealth Group Inc has a 1 year low of $208.07 and a 1 year high of $287.94. The company has a market cap of $209.66 billion, a PE ratio of 17.35, a price-to-earnings-growth ratio of 1.18 and a beta of 0.60.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, July 18th. The healthcare conglomerate reported $3.60 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $3.46 by $0.14. UnitedHealth Group had a net margin of 5.51% and a return on equity of 25.20%. The firm had revenue of $60.60 billion during the quarter, compared to the consensus estimate of $60.59 billion. During the same period last year, the firm posted $3.14 EPS. The firm’s revenue for the quarter was up 8.0% on a year-over-year basis. On average, research analysts expect that UnitedHealth Group Inc will post 14.83 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th were paid a dividend of $1.08 per share. The ex-dividend date of this dividend was Friday, September 13th. This represents a $4.32 annualized dividend and a dividend yield of 1.93%. UnitedHealth Group’s dividend payout ratio is currently 33.54%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Further Reading: Why is the Consumer Price Index (CPI) important?

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.